Pro-Dex, Inc.

NASDAQ:PDEX

Medical - Instruments & Supplies

Healthcare
$63.94 +5.86%

+$3.54 today

Market cap
$204.61M
Beta
-0.00
P/E (TTM)
17.1
EPS (TTM)
$3.75
52W Low $23.47High $68.99

Volume 0.04M

Average 0.04M

PDEX Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Pro-Dex, Inc.NASDAQ: PDEX

Common Stock · Q3 FY2026 · quarter ended Mar 2026

Common stock remains negative

Q3 FY2026 common stock was $0, compared with $551K a year earlier. Over 3 fiscal years it compounded at -54.9% a year.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q3 FY2026, down 0.9 pp from a year earlier.
  • Common stock increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps falling in the next quarterly balance sheet after a -100.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearJun 2025
$704K-82.0% YoY
Year agoMar 2025
$551K-100.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-100.0%——
1 year-82.0%——
3-year CAGR-54.9%——
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
704K USD
Year-over-year change
-82.0%
4-year CAGR
-45.0%

Common Stock vs competitors

How PDEX compares with its peers on the latest reported figures

  • PDEX's Mar 2026 common stock of $0 is the lowest of the 9 companies compared; the peer median is $66K.
  • Its year-over-year change of -100.0% is the lowest of 9, against a peer median of +28.2%.
  • Common stock amounts to 0.0% of total assets for PDEX, versus a peer median of 0.2%.
PDEX Competitors Peer median
Common Stock for PDEX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
MBOTMicrobot Medical Inc.Mar 2026$672K +93.1%+103.3%0.9%
RPIDRapid Micro Biosystems, Inc.Mar 2026$458K +4.8%+1.9%0.7%
LUCDLucid Diagnostics Inc.Mar 2026$165K +96.4%+47.3%0.5%
CGTXCognition Therapeutics, Inc.Mar 2026$90K +45.2%+45.9%0.2%
APYXApyx Medical CorporationMar 2026$42K +10.5%+6.3%0.1%
GLSIGreenwich LifeSciences, Inc.Mar 2026$14.67K +11.2%+3.6%0.1%
STSSSkyAI, Inc.Mar 2026$4.03K +8291.7%+45.5%0.0%
SERASera Prognostics, Inc.Mar 2026$4K +0.0%+10.1%0.0%
PDEXPro-Dex, Inc.Mar 2026$0 -100.0%-54.9%0.0%
Peer median (excluding PDEX) $66K+28.2%+27.8%0.2%

Competitors are the stored peer set for PDEX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Cash & Equivalents849K849K2.94M2.63M419K
Short-term Investments755K755K1.13M4.22M6.74M
Net Receivables15.38M15.38M9.95M13.89M17.49M
Inventory12.68M12.68M16.17M15.27M22.21M
Other Current Assets710K710K494K262K24K
Total Current Assets31.17M31.17M30.98M36.61M47.3M
Property, Plant & Equipment (Net)13.42M13.42M13.2M12.65M1.05M
Goodwill00000
Intangible Assets118K118K81K54K26K
Long-term Investments4.08M4.08M7.52M1.56M148K
Tax Assets256K256K01.56M1.42M
Other Non-current Assets42K42K42K42K11.26M
Total Non-current Assets17.92M17.92M20.84M15.87M13.9M
Total Assets49.09M49.09M51.82M52.48M61.19M
Account Payables3.76M3.76M2.26M4.51M4.61M
Short-term Debt3.29M3.29M3.83M4.37M6.15M
Tax Payables544K544K453K632K186K
Deferred Revenue1.01M1.01M014K202K
Other Current Liabilities00001.63M
Total Current Liabilities11.35M11.35M9.68M12.89M14.63M
Long-term Debt10.25M10.25M8.91M7.54M9.25M
Deferred Tax Liabilities008K00
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities12.3M12.3M10.56M8.72M9.93M
Total Liabilities23.66M23.66M20.23M21.61M24.56M
Common Stock7.68M7.68M6.77M3.92M704K
Retained Earnings17.75M17.75M24.82M26.95M35.93M
Accumulated OCI00000
Other Stockholders Equity00000
Minority Interest00000
Total Equity25.43M25.43M31.59M30.87M36.63M
Total Debt15.97M15.97M14.79M13.55M16.58M
Net Debt15.12M15.12M11.86M10.92M16.16M

Pro-Dex, Inc.

NASDAQ:PDEX

Intrinsic Alpha fair value

Locked

Current Price

$63.94

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.